Added to YB: 2025-08-20
Pitch date: 2025-08-18
ZTS [bullish]
Zoetis Inc.
-19.13%
current return
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
Market Cap
$53.3B
Pitch Price
$152.39
Price Target
N/A
Dividend
1.75%
EV/EBITDA
14.33
P/E
20.38
EV/Sales
6.23
Sector
Pharmaceuticals
Category
growth
Zoetis Inc. - $ZTS
ZTS (overview): Leading animal health company, $67.8B cap, $74.6B EV. Q1 2025 revenue $2.2B (+1% YoY, +9% organic), net income $631M ($1.41/share). Trades at 26.3x P/E with $5.82 EPS, $4.99 FCFS. Diversified portfolio across livestock/companion animals. 1.3% dividend yield. Recent $1.85B senior notes to repay 2025 debt. Increased 2025 outlook after Q2.
Read full article (3 min)